EAM
OM icon

Eventide Asset Management’s Outset Medical OM Stock Holding History

Eventide Asset Management’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,600
Closed -$3.13M – 144
2022
Q1 		$3.13M Hold
4,600
– – 0.05% 129
2021
Q4 		$3.18M Buy
4,600
+306
+7% +$226K 0.04% 140
2021
Q3 		$3.18M Buy
4,294
+470
+12% +$320K 0.04% 146
2021
Q2 		$2.87M Buy
3,824
+1,408
+58% +$1.08M 0.04% 145
2021
Q1 		$1.97M Buy
2,416
+667
+38% +$515K 0.03% 149
2020
Q4 		$1.49M Buy
1,749
+840
+92% +$647K 0.02% 150
2020
Q3 		$682K Buy
+909
New +$746K 0.01% 138

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Eventide Asset Management's OM Position: Q2 2022 in Review

Eventide Asset Management sold out of Outset Medical (OM) in Q2 2022, closing a stake of 4,600 shares — an estimated $3.13M sold.

Eventide Asset Management first reported a position in OM in Q3 2020 and held it in 7 quarters. The position peaked at $3.18M in Q3 2021. 149 funds tracked by Wall St. Rank hold OM as of Q2 2022.

  • Eventide Asset Management reported no remaining Outset Medical position as of Q2 2022 after selling out during the quarter.
  • Eventide Asset Management sold 4,600 Outset Medical shares in Q2 2022, an estimated $3.13M.
  • Eventide Asset Management first reported a position in Outset Medical in Q3 2020 and held it in 7 quarters.
  • Eventide Asset Management's Outset Medical position peaked at $3.18M in Q3 2021.
  • 149 funds tracked by Wall St. Rank held Outset Medical as of Q2 2022.

Based on Eventide Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.